Cargando…

Advantages of Structure-Based Drug Design Approaches in Neurological Disorders

OBJECTIVE: The purpose of the review is to portray the theoretical concept on neurological disorders from research data. BACKGROUND: The freak changes in chemical response of nerve impulse causes neurological disorders. The research evidence of the effort done in the older history suggests that the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aarthy, Murali, Panwar, Umesh, Selvaraj, Chandrabose, Singh, Sanjeev Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725545/ https://www.ncbi.nlm.nih.gov/pubmed/28042767 http://dx.doi.org/10.2174/1570159X15666170102145257

Ejemplares similares

Structural dynamic studies on identification of EGCG analogues for the inhibition of Human Papillomavirus E7
por: Aarthy, Murali, et al.
Publicado: (2020)

Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries
por: Selvaraj, Chandrabose, et al.
Publicado: (2021)

Microsecond MD Simulation and Multiple-Conformation Virtual Screening to Identify Potential Anti-COVID-19 Inhibitors Against SARS-CoV-2 Main Protease
por: Selvaraj, Chandrabose, et al.
Publicado: (2021)

Structure-Based Virtual Screening Reveals Ibrutinib and Zanubrutinib as Potential Repurposed Drugs against COVID-19
por: Kaliamurthi, Satyavani, et al.
Publicado: (2021)

Interpretations on the Interaction between Protein Tyrosine Phosphatase and E7 Oncoproteins of High and Low-Risk HPV: A Computational Perception
por: Aarthy, Murali, et al.
Publicado: (2021)

Unraveling the multi-targeted curative potential of bioactive molecules against cervical cancer through integrated omics and systems pharmacology approach
por: Aarthy, Murali, et al.
Publicado: (2022)

Mechanistic Insights into Zika Virus NS3 Helicase Inhibition by Epigallocatechin-3-Gallate
por: Kumar, Deepak, et al.
Publicado: (2020)

A database for the predicted pharmacophoric features of medicinal compounds
por: Daisy, Pitchai, et al.
Publicado: (2011)

Molecular drug targets and structure based drug design: A holistic approach
por: Singh, Shailza, et al.
Publicado: (2006)

Interrogation of Bacillus anthracis SrtA active site loop forming open/close lid conformations through extensive MD simulations for understanding binding selectivity of SrtA inhibitors
por: Selvaraj, Chandrabose, et al.
Publicado: (2021)

Homology modeling, active site prediction, and targeting the anti hypertension activity through molecular docking on endothelin – B receptor domain
por: Rayalu, Daddam Jayasimha, et al.
Publicado: (2012)

Hydroxychloroquine Inhibits Zika Virus NS2B-NS3 Protease
por: Kumar, Ankur, et al.
Publicado: (2018)

In Silico and In Vitro Studies on the Protein-Protein Interactions between Brugia malayi Immunomodulatory Protein Calreticulin and Human C1q
por: Yadav, Sunita, et al.
Publicado: (2014)

Editorial: Structure-Based Drug Design for Diagnosis and Treatment of Neurological Diseases
por: Ramsay, Rona R., et al.
Publicado: (2017)

Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders
por: Sim, Tao Ming, et al.
Publicado: (2020)

Editorial: Novel Therapeutic Interventions Against Infectious Diseases: COVID-19
por: Sakkiah, Sugunadevi, et al.
Publicado: (2022)

An In silico Approach to Identify High Affinity Small Molecule Targeting m-TOR Inhibitors for the Clinical Treatment of Breast Cancer
por: Patidar, Khushboo, et al.
Publicado: (2019)

Silibinin and Naringenin against Bisphenol A-Induced Neurotoxicity in Zebrafish Model—Potential Flavonoid Molecules for New Drug Design, Development, and Therapy for Neurological Disorders
por: Thayumanavan, Geethanjali, et al.
Publicado: (2022)

Neurotrophic factor-based pharmacological approaches in neurological disorders
por: Alfonsetti, Margherita, et al.
Publicado: (2022)

Selectins—The Two Dr. Jekyll and Mr. Hyde Faces of Adhesion Molecules—A Review
por: Tvaroška, Igor, et al.
Publicado: (2020)

Implications of Withaferin A in neurological disorders
por: Ram, Natasha, et al.
Publicado: (2020)

Structure-based drug designing and immunoinformatics approach for SARS-CoV-2
por: Panda, Pritam Kumar, et al.
Publicado: (2020)

Drug repositioning for psychiatric and neurological disorders through a network medicine approach
por: Lüscher Dias, Thomaz, et al.
Publicado: (2020)

Innovative Approaches and Therapies to Enhance Neuroplasticity and Promote Recovery in Patients With Neurological Disorders: A Narrative Review
por: Kumar, Jitesh, et al.
Publicado: (2023)

Advantages and Limitations of Androgen Receptor-Based Methods for Detecting Anabolic Androgenic Steroid Abuse as Performance Enhancing Drugs
por: Bailey, Kathy, et al.
Publicado: (2016)

2333. Influenza-Related Neurologic Complications in Hospitalized Children with Underlying Neurologic Disorders
por: Frankl, Sarah, et al.
Publicado: (2019)

The Open Form Inducer Approach for Structure-Based Drug Design
por: Inaoka, Daniel Ken, et al.
Publicado: (2016)

Editorial: Chemoinformatics Approaches to Structure- and Ligand-Based Drug Design
por: Ferreira, Leonardo L. G., et al.
Publicado: (2018)

Advantages of mini-multileaf in stereotactic radiotherapy
por: Kurup, P. G. G., et al.
Publicado: (2007)

Gut microbiota-derived metabolites and their importance in neurological disorders
por: Swer, Nicole Mary, et al.
Publicado: (2022)

COVID-19 vaccine-related functional neurological disorders in the emergency department
por: Sanjeev, Om P., et al.
Publicado: (2022)

Potential therapeutics against neurological disorders: Natural products-based drugs
por: Rauf, Abdur, et al.
Publicado: (2022)

A molecular simulation approach towards the development of universal nanocarriers by studying the pH- and electrostatic-driven changes in the dynamic structure of albumin
por: Srivastav, Amit Kumar, et al.
Publicado: (2020)

Identification of Mtb GlmU Uridyltransferase Domain Inhibitors by Ligand-Based and Structure-Based Drug Design Approaches
por: Singh, Manvi, et al.
Publicado: (2022)

Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations
por: Zorkina, Yana, et al.
Publicado: (2020)

Integrating design and manufacturing for competitive advantage
Publicado: (1992)

Computer-Aided Drug Design towards New Psychotropic and Neurological Drugs
por: Dorahy, Georgia, et al.
Publicado: (2023)

Targeting pericytes for therapeutic approaches to neurological disorders
por: Cheng, Jinping, et al.
Publicado: (2018)

Approach to Neurological Channelopathies and Neurometabolic Disorders in Newborns
por: Lee, Inn-Chi
Publicado: (2021)

Treatment Approaches for Functional Neurological Disorders in Children
por: Vassilopoulos, Areti, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_24o7poont7uqa6oma6o321au34